In the face of global Antimicrobial Resistance (AMR), we provide stabilized Amoxycillin formulations that ensure precise dosing and therapeutic efficacy, reducing the risk of resistance development in diverse populations.
The global amoxycillin market is projected to grow steadily, driven by increasing respiratory tract infections and the expansion of healthcare access in emerging economies. We bridge the gap between high-demand regions and premium manufacturing.
We strictly adhere to GMP, BP, and USP standards. Our regulatory team provides full support for DMF filing and local registration, ensuring seamless entry into markets across Asia, Africa, and Latin America.
Effective against Streptococcus pneumoniae, it remains the first-line treatment for community-acquired pneumonia, acute sinusitis, and bronchitis.
Crucial component of the "triple therapy" for gastric ulcers, combined with proton pump inhibitors and other antibiotics to eliminate H. pylori infection.
Our formulation expertise allows for stable dosage forms that are safe and effective for sensitive age groups, maintaining consistent therapeutic windows.
Our manufacturing process utilizes Co-Crystallization and Bio-Fermentation technologies to enhance the purity of the Amoxycillin Trihydrate API. By controlling the crystal habit, we ensure that the capsules provide optimal dissolution rates, meeting the most stringent international pharmacopeia requirements.
Integration of AI-driven supply chain management to predict demand fluctuations and prevent stockouts of critical antibiotics in remote regions.
Transitioning toward "Green Chemistry" in the synthesis of β-lactam intermediates, reducing the environmental footprint of antibiotic production.
Development of combination therapies (e.g., Amoxycillin + Clavulanate) with controlled-release micro-granule technology for once-daily dosing.
A: Amoxycillin Trihydrate contains three water molecules per molecule of antibiotic, which significantly improves its stability in solid dosage forms and its shelf-life in various climatic conditions compared to the anhydrous form.
A: We leverage over 10 years of export experience, conduct on-site audits of our 200+ partner factories, and provide full transparency through GMP certifications and batch-specific COAs (Certificate of Analysis).
A: No, Amoxycillin is strictly for bacterial infections. Misuse for viruses contributes to AMR. We provide educational resources to our clients to promote responsible antibiotic usage.
A: We offer dossier preparation for CTD formats, support for WHO pre-qualification, and specialized shipping routes to ensure cold-chain or temperature-controlled logistics where necessary.
